1007-3639
2015 Issue 3
miR-222 can inhibit the autophagy of renal cell carcinoma cells through down-regulating the expression of DDIT4
NI Xiaochen;,ZHAO Zhihong;,MA Yongliang;,REN Zongtao;,LIU Bin;,ZHANG Aili;
NI Xiaochen;,ZHAO Zhihong;,MA Yongliang;,REN Zongtao;,LIU Bin;,ZHANG Aili;
..............page:161-166
The apoptosis induction on K562 cells by the CML bcr-abl gene antisense oligonucleotides
PING Juan;,ZHAO Na;,WANG Baoquan;,SHEN Zhihui;,YIN Mingxing;,PANG Xiaobin;,CHEN Chuanbo;
PING Juan;,ZHAO Na;,WANG Baoquan;,SHEN Zhihui;,YIN Mingxing;,PANG Xiaobin;,CHEN Chuanbo;
..............page:167-172
Effects of progranulin on proliferation and senescence in gastric cancer cells
LI Yuanyuan;,WANG Hongyan;,WU Xiaoyan;,SONG Ruihui;,LI Jing;
LI Yuanyuan;,WANG Hongyan;,WU Xiaoyan;,SONG Ruihui;,LI Jing;
..............page:173-178
The expression and signiifcance of PRR11 protein in human pancreatic carcinoma
TAO Jiashou;,LI Yunfeng;,LUO Xiao;,CHEN Meifu;
TAO Jiashou;,LI Yunfeng;,LUO Xiao;,CHEN Meifu;
..............page:179-183
..............page:183-183
A functional variant at miR-520a binding site in PIK3CA alters susceptibility to colorectal cancer in a Chinese Han population
DING Lifang;,JIANG Zao;,CHEN Qiaoyun;,QIN Rong;,FANG Yue;,LI Hao;
DING Lifang;,JIANG Zao;,CHEN Qiaoyun;,QIN Rong;,FANG Yue;,LI Hao;
..............page:184-189
Expressions of miRNA27a and miRNA451 in ovarian cancer and breast cancer cells and its correlation with drug resistance by targeting MDR1/P-glycoprotein
LI Zhimin;,LUO Xiping;,ZENG Liqin;,PENG Xiuhong;,WANG Yi;,WANG Zehua;
LI Zhimin;,LUO Xiping;,ZENG Liqin;,PENG Xiuhong;,WANG Yi;,WANG Zehua;
..............page:190-198
The value of subsolid pulmonary nodules in imaging diagnosis of stage ⅠA lung cancer
HUANG Haozhe;,LI Guodong;,XU Lichao;,LI Wentao;,WANG Shengping;
HUANG Haozhe;,LI Guodong;,XU Lichao;,LI Wentao;,WANG Shengping;
..............page:199-204
..............page:204-204
Application of DWI with various b values in diagnosis of clear cell renal cell carcinoma Fuhrman grades SHEN
Lijuan;,ZHOU Liangping;,PENG Weijun;,YANG Xiaoqun;,YUE Lei;
Lijuan;,ZHOU Liangping;,PENG Weijun;,YANG Xiaoqun;,YUE Lei;
..............page:205-210
Dose escalation of lobaplatin combined with ifxed docetaxel in second-line chemotherapy with solid tumors
LIU Yue’e;,REN Xiaocang;,CHEN Xueji;,MA Yan;,LI Jing;,PENG Yu;,GUO Zhijun;,CAO Bin;,LIN Qiang;
LIU Yue’e;,REN Xiaocang;,CHEN Xueji;,MA Yan;,LI Jing;,PENG Yu;,GUO Zhijun;,CAO Bin;,LIN Qiang;
..............page:211-216
Outcomes and clinical prognostic factors for elderly patients with esophageal squamous cell carcinoma treated after definitive chemoradiotherapy
LV Bo;,CHEN Yun;,LI Yunhai;,ZHU Hong;,ZHAO Kuaile;
LV Bo;,CHEN Yun;,LI Yunhai;,ZHU Hong;,ZHAO Kuaile;
..............page:217-221
The treatment for acquired drug resistance of clinical characteristics of patients with non-small cell lung cancer
ZHOU Xin;,LI Xiaoqin;,WANG Xiuli;,GU Guomin;,LIU Chunling;
ZHOU Xin;,LI Xiaoqin;,WANG Xiuli;,GU Guomin;,LIU Chunling;
..............page:222-230
..............page:230-230
Clinical advancement of hypercoagulability in patients with ovarian cancer
FENG Zheng;,WEN Hao;,WU Xiaohua;
FENG Zheng;,WEN Hao;,WU Xiaohua;
..............page:231-234
Treatment progress of thyroid cancer in children and adolescents
CHEN Jiaying;,ZHANG Ling;,JI Qinghai;
CHEN Jiaying;,ZHANG Ling;,JI Qinghai;
..............page:235-240